Home > Financial Ratios > LYKA LABS

LYKA LABS
Working Capital/Sales

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 13.706.668.638.02-4.12

What is the latest Working Capital/Sales ratio of LYKA LABS ?

The latest Working Capital/Sales ratio of LYKA LABS is 13.70 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar202613.70
Mar20256.66
Mar20248.63
Mar20238.02
Mar2022-4.12

How is Working Capital/Sales of LYKA LABS Trending?

Years Working Capital/Sales % Change
Mar2026 13.7
105.71
Mar2025 6.66
-22.83
Mar2024 8.63
7.61
Mar2023 8.02
Positive
Mar2022 -4.12 -

Other Financial Ratios of LYKA LABS


Compare Working Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹267.8 Cr -10.3% -8.1% -24.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-10.3%

-8.1%

-24.3%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses